Showing 85–96 of 112 results

Talzenna 1 mg Alternative – Talaparib (Talazoparib) 1 mg Capsule | Everest Pharmaceuticals

Talaparib 1 mg (Talazoparib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Talzenna (Pfizer). It belongs to the PARP inhibitor class and is used in selected genetically defined breast and prostate cancer treatment settings.

Active ingredient: Talazoparib
Strength: 1 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Tarceva 100 mg Alternative – Erlocent (Erlotinib) 100 mg Tablet | Incepta Pharmaceuticals

Erlocent 100 mg (Erlotinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Tarceva (Roche / Genentech).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Tarceva 100 mg Alternative – Erlonix (Erlotinib) 100 mg Tablet | Beacon Pharmaceuticals

Erlonix 100 mg (Erlotinib) Tablet by Beacon Pharmaceuticals. Reference brand: Tarceva. EGFR inhibitor; used in selected EGFR-mutated non-small cell lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Tarceva 150 mg Alternative – Erlocent (Erlotinib) 150 mg Tablet | Incepta Pharmaceuticals

Erlocent 150 mg (Erlotinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Tarceva (Roche / Genentech).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Tarceva 150 mg Alternative – Erlonix (Erlotinib) 150 mg Tablet | Beacon Pharmaceuticals

Erlonix 150 mg (Erlotinib) Tablet by Beacon Pharmaceuticals. Reference brand: Tarceva. EGFR inhibitor; used in selected EGFR-mutated non-small cell lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Temodar 100 mg Alternative – Temonix (Temozolomide) 100 mg Capsule | Beacon Pharmaceuticals

Temonix 100 mg (Temozolomide) Capsule by Beacon Pharmaceuticals. Reference brand: Temodar. alkylating chemotherapy; used in selected brain tumors including glioblastoma. Prescription medicine. Brand comparison does not establish interchangeability.

Temodar 250 mg Alternative – Temonix (Temozolomide) 250 mg Capsule | Beacon Pharmaceuticals

Temonix 250 mg (Temozolomide) Capsule by Beacon Pharmaceuticals. Reference brand: Temodar. alkylating chemotherapy; used in selected brain tumors including glioblastoma. Prescription medicine. Brand comparison does not establish interchangeability.

Tukysa 150 mg Alternative – Tucaxen (Tucatinib) 150 mg Tablet | Everest Pharmaceuticals

Tucaxen 150 mg (Tucatinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Tukysa (Seagen / Pfizer). It belongs to the HER2 tyrosine kinase inhibitor class and is used in selected HER2-positive breast cancer treatment combinations.

Active ingredient: Tucatinib
Strength: 150 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Tykerb / Tyverb 250 mg Alternative – Lapacent (Lapatinib) 250 mg Tablet | Incepta Pharmaceuticals

Lapacent 250 mg (Lapatinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Tykerb / Tyverb (Novartis).

Pack: 12 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Tykerb 250 mg Alternative – Certus (Lapatinib) 250 mg Tablet | Beacon Pharmaceuticals

Certus 250 mg (Lapatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Tykerb. HER2/EGFR inhibitor; used in selected HER2-positive breast cancer combinations. Prescription medicine. Brand comparison does not establish interchangeability.

Venclexta 10 mg Alternative – Venclax (Venetoclax) 10 mg Tablet | Beacon Pharmaceuticals

Venclax 10 mg (Venetoclax) Tablet by Beacon Pharmaceuticals. Reference brand: Venclexta. BCL-2 inhibitor; used in selected chronic lymphocytic leukemia and acute myeloid leukemia. Prescription medicine. Brand comparison does not establish interchangeability.

Venclexta 100 mg Alternative – Venclax (Venetoclax) 100 mg Tablet | Beacon Pharmaceuticals

Venclax 100 mg (Venetoclax) Tablet by Beacon Pharmaceuticals. Reference brand: Venclexta. BCL-2 inhibitor; used in selected chronic lymphocytic leukemia and acute myeloid leukemia. Prescription medicine. Brand comparison does not establish interchangeability.